Literature DB >> 21920539

The growing impact of pediatric pharmaceutical poisoning.

G Randall Bond1, Randall W Woodward, Mona Ho.   

Abstract

OBJECTIVE: To understand which medications, under which circumstances, are responsible for the noted increase in pediatric medication poisonings, resource use, and morbidity. STUDY
DESIGN: Patient records from 2001-2008 were obtained from the National Poison Data System of the American Association of Poison Control Centers for children aged ≤5 years evaluated in a health care facility following exposure to a potentially toxic dose of a pharmaceutical agent. Pharmaceutical agents were classified as over-the-counter or prescription and by functional category. Exposures were classified as child self-ingested the medication or as therapeutic error. For the 8-year period, emergency visits, admissions, significant injuries, and trends in these events were calculated for each substance category.
RESULTS: We evaluated 453 559 children for ingestion of a single pharmaceutical product. Child self-exposure was responsible for 95% of visits. Child self-exposure to prescription products dominated the health care impact with 248 023 of the visits (55%), 41 847 admissions (76%), and 18 191 significant injuries (71%). The greatest resource use and morbidity followed self-ingestion of prescription products, particularly opioids, sedative-hypnotics, and cardiovascular agents.
CONCLUSIONS: Prevention efforts have proved to be inadequate in the face of rising availability of prescription medications, particularly more dangerous medications.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920539     DOI: 10.1016/j.jpeds.2011.07.042

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  35 in total

Review 1.  Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Authors:  Daniel P Wermeling
Journal:  Ther Adv Drug Saf       Date:  2015-02

2.  Opioid Prescribing and Potential Overdose Errors Among Children 0 to 36 Months Old.

Authors:  William T Basco; Myla Ebeling; Sandra S Garner; Thomas C Hulsey; Kit Simpson
Journal:  Clin Pediatr (Phila)       Date:  2015-05-13       Impact factor: 1.168

3.  Unused prescription drugs should not be treated like leftovers.

Authors:  Peter E Wu; David N Juurlink
Journal:  CMAJ       Date:  2014-05-05       Impact factor: 8.262

4.  Indications for Use of Combination Acetaminophen/Opioid Drugs in Infants <6 Months Old.

Authors:  William T Basco; James R Roberts; Myla Ebeling; Sandra S Garner; Thomas C Hulsey; Kit Simpson
Journal:  Clin Pediatr (Phila)       Date:  2017-09-11       Impact factor: 1.168

5.  Effect of a Scenario-tailored Opioid Messaging Program on Parents' Risk Perceptions and Opioid Decision-making.

Authors:  Terri Voepel-Lewis; Brian J Zikmund-Fisher; Carol J Boyd; Philip T Veliz; Sean E McCabe; Monica J Weber; Alan R Tait
Journal:  Clin J Pain       Date:  2018-06       Impact factor: 3.442

6.  Adherence to label and device recommendations for over-the-counter pediatric liquid medications.

Authors:  Daniel S Budnitz; Maribeth C Lovegrove; Kathleen O Rose
Journal:  Pediatrics       Date:  2014-01-06       Impact factor: 7.124

7.  Death by band-aid: fatal misuse of transdermal fentanyl patch.

Authors:  Marija Bakovic; Marina Nestic; Davor Mayer
Journal:  Int J Legal Med       Date:  2015-06-09       Impact factor: 2.686

Review 8.  Prevention of Pediatric Pharmaceutical Poisonings.

Authors:  Nicole D White; William Kibalama
Journal:  Am J Lifestyle Med       Date:  2017-12-09

9.  Efficacy of flow restrictors in limiting access of liquid medications by young children.

Authors:  Maribeth C Lovegrove; Stephanie Hon; Robert J Geller; Kathleen O Rose; Lee M Hampton; Jill Bradley; Daniel S Budnitz
Journal:  J Pediatr       Date:  2013-07-26       Impact factor: 4.406

10.  Adult prescription drug use and pediatric medication exposures and poisonings.

Authors:  Lindsey C Burghardt; John W Ayers; John S Brownstein; Alvin C Bronstein; Michele Burns Ewald; Florence T Bourgeois
Journal:  Pediatrics       Date:  2013-06-03       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.